MA39120A1 - Substituted piperidinyl-tetrahydroquinolines antagonists adrenergic alpha-2c receptors. - Google Patents
Substituted piperidinyl-tetrahydroquinolines antagonists adrenergic alpha-2c receptors.Info
- Publication number
- MA39120A1 MA39120A1 MA39120A MA39120A MA39120A1 MA 39120 A1 MA39120 A1 MA 39120A1 MA 39120 A MA39120 A MA 39120A MA 39120 A MA39120 A MA 39120A MA 39120 A1 MA39120 A1 MA 39120A1
- Authority
- MA
- Morocco
- Prior art keywords
- diabetic
- diseases
- tetrahydroquinolines
- prevention
- treatment
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne de nouvelles pipéridinyl-tétrahydroquinoléines substituées, des procédés pour leur production, leur utilisation dans le traitement et/ou la prévention de maladies et leur utilisation dans la production de médicaments destinés au traitement et/ou à la prévention de maladies, notamment le traitement et/ou la prévention de microangiopathies diabétiques, d'ulcères diabétiques aux extrémités, notamment pour favoriser la cicatrisation des ulcères du pied diabétique, l'insuffisance cardiaque diabétique, les maladie cardiaque microvasculaire coronariennes diabétiques, les maladies vasculaires cardiaques et périphériques, les maladies et les ischémies thromboemboliques, les troubles circulatoires périphériques, le syndrome de raynaud, le syndrome de crest, les déficiences de la microcirculation, la claudication intermittente, et les neuropathies périphériques et autonomes.The present invention relates to novel substituted piperidinyl tetrahydroquinolines, processes for their production, their use in the treatment and / or prevention of diseases and their use in the production of medicaments for the treatment and / or prevention of diseases, in particular the treatment and / or prevention of diabetic microangiopathies, diabetic ulcers at the extremities, in particular to promote the healing of diabetic foot ulcers, diabetic heart failure, diabetic coronary microvascular heart disease, cardiac and peripheral vascular diseases, thromboembolic diseases and ischemia, peripheral circulatory disorders, raynaud syndrome, crest syndrome, microcirculatory deficiencies, intermittent claudication, and peripheral and autonomic neuropathies.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13198388 | 2013-12-19 | ||
PCT/EP2014/077865 WO2015091417A1 (en) | 2013-12-19 | 2014-12-16 | Substituted piperidinyl-tetrahydroquinolines |
Publications (1)
Publication Number | Publication Date |
---|---|
MA39120A1 true MA39120A1 (en) | 2017-11-30 |
Family
ID=49876402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA39120A MA39120A1 (en) | 2013-12-19 | 2014-12-16 | Substituted piperidinyl-tetrahydroquinolines antagonists adrenergic alpha-2c receptors. |
Country Status (1)
Country | Link |
---|---|
MA (1) | MA39120A1 (en) |
-
2014
- 2014-12-16 MA MA39120A patent/MA39120A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY177393A (en) | Substituted piperidinyl-tetrahydroquinolines and their use as alpha-2c adrenoreceptor antagonists | |
MA34721B1 (en) | SUBSTITUTED 1-BENZYLCYCLOALKYL CARBOXYLIC ACIDS AND USE THEREOF | |
MA33123B1 (en) | 2-Astmedo-5-aryl-1,2,4-triazolone substitute and its use | |
MA35365B1 (en) | Ringed Pyrimidines substituted and their use | |
PH12016501146A1 (en) | Substituted piperidinyl - tetrahydroquinolines | |
NO20073651L (en) | Antiangiogenesis therapy of autoimmune disease in patients with failed previous therapy | |
WO2006098603A3 (en) | Composition comprising isoorientin for suppressing histamine | |
MA47356B1 (en) | Isochromene derivatives useful as inhibitors of phosphoinositide 3-kinases | |
HRP20200009T1 (en) | Angiotensin ii in combination for the treatment of hypotension | |
WO2015066700A3 (en) | Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation | |
MA31535B1 (en) | SUBSTITUTED (OXAZOLIDINON-5-YL-METHYL) -2-THIOPHENER CARBOXAMIDES AND THEIR USE IN THE FIELD OF BLOOD COAGULATION | |
MA34106B1 (en) | COMBINATION OF ORGANIC COMPOUNDS | |
MA39120A1 (en) | Substituted piperidinyl-tetrahydroquinolines antagonists adrenergic alpha-2c receptors. | |
MD3886857T2 (en) | Montelukast for the treatment of erosive hand osteoarthritis | |
ATE527256T1 (en) | SUBSTITUTED (OXAZOLIDINONE-5-YL-METHYL)-2- THIOPHENE CARBOXAMIDES AND THEIR USE IN THE FIELD OF BLOOD CLOTTING | |
ATE502637T1 (en) | MEDICATIONS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE USING AN ANTICHOLINERGIC | |
MA39122A1 (en) | Piperidinyl-tetrahydrochinolines substituted adrenergic antagonists of alpha-2c receptors. | |
NI201200008A (en) | OTAMIXABAN FOR THE TREATMENT OF OLD-AGED AND KIDNEY DISORDERS WITH NON-ST-ELEVATION MYOCARDIAL INFARCTION | |
EA201590825A1 (en) | WAYS OF CONTROLING BLOOD PRESSURE AND REDUCING DISPERSE IN HEART FAILURE | |
WO2011100453A3 (en) | Compositions and methods for the treatment of cardiac and vascular disease | |
SE0401943D0 (en) | New use | |
EA202091446A1 (en) | METHODS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | |
EA201200443A1 (en) | COMBINED MEDICINE AND METHOD FOR TREATING VENOUS CEREBRAL DISCRIRCULATION | |
BR112022003917A2 (en) | Rebamipide for use in the prevention and/or treatment of arterial stiffness | |
FR3075602B1 (en) | COMBINATION PRODUCT FOR THE PREVENTION AND TREATMENT OF CHRONIC VENOUS INSUFFICIENCY |